Ceapro Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference September 14, 2020
Ceapro Inc. Reports 2020 Second Quarter and Six-Month Financial Results and Operational Highlights August 20, 2020
Ceapro Inc. Announces Publication of Positive Results from Study Evaluating Avenanthramides in Exercise-Induced Inflammation August 4, 2020
Ceapro Inc. Announces Publication of Positive Results for a PGX Processed Drug Delivery System for Accelerated Burn Wound Healing June 15, 2020
Ceapro Inc. Expands Collaborative Research Program with McMaster University to Develop Inhalable Therapeutic for COVID-19 May 26, 2020
